Results

Total Results: 1,544 records

Showing results for "drug".

461. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Food and Drug Administration (FDA) marketing submission. … Food and Drug Administration (FDA); 2012 Mar 22. 30 p. 9. … Food and Drug Administration (FDA); 2012 Dec 3 [accessed 2012 Dec 5]. [2 p]. … Food and Drug Administration (FDA); 2012 Dec 3 [accessed 2012 Dec 5]. [2 p]. … Specialty drug list. [internet].

462. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
     May 01, 2008 - Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD. 2 Peter Lamy Center on Drug … settings was also found despite the different method of measuring medication use, with institutional drug … This relationship also held in the community, albeit overall rates of drug use were lower (15.5% versus … particularly important to replicate this work given that new drugs (specifically memantine) and other drug … The quality of antipsychotic drug prescribing in nursing homes.

463. Hip-Fracture-Pain Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_consumer.pdf
     May 01, 2011 - Managing Pain From a Broken Hip A Guide for Adults and Their Caregivers Is This Guide Right for Me or Someone I Care For? Yes, if: � You or the person you care for is an older adult (more than 50 years old) who is in a hospital because of a hip fracture (a broken hip that occurs suddenly from an event like a…

464. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
     December 06, 2016 - and Human Services (HHS), the Centers for Diseases Control and Prevention (CDC), and the Food and Drug … According to the Drug Enforcement Agency8 six states allow pharmacists to prescribe Schedule III, IV … We utilize a full diversion control protocol – monitoring drug tests for nor- buprenorphine levels, … random call backs, random pill counts and drug tests, checking not only the state’s Prescription Drug … Drug and alcohol dependence. 2014 Jul 1;140:118-22.) Thank you for your comment.

465. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Food and Drug Administration (FDA) does not regulate human milk banking but offers guidelines and provisions … research expert stated, “With the use of banked [human donor] milk, babies born to mothers with HIV, drug … Food and Drug Administration (FDA); [accessed 2011 Mar 2]. [6 p]. … Food and Drug Administration Center for Food Safety and Applied Nutrition; 2010 Dec 6. 6 p.

466. Tinnitus Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
     August 01, 2013 - 1 Comparative Effectiveness Review Number 122 Evaluation and Treatment of Tinnitus: Comparative Effectiveness Executive Summary Background Tinnitus is the perception of sound in the absence of an external auditory stimulus; as such, tinnitus is a symptom, not a disease. An estimated 16 percent of the America…

467. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Food and Drug Administration approved in November 2012 for treating adults with moderately to severely … Third-party payer policies were not identified as of this writing, but the drug would likely be listed …  Key Expert Comments: Overall, experts thought that the drug could address the unmet need for … Food and Drug Administration (FDA)–compliant manner will be needed in many locations where there may … Food and Drug Administration (FDA); 2012 Nov 6 [accessed 2012 Nov 12]. [2 p].

468. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - FDA = Food and Drug Administration; N/A = not applicable; NSAID = nonsteroidal anti-inflammatory drug … Adverse events associated with colchicine drug interactions: Analysis of the public version of the … Drug Saf. 2013 Oct;36(10):953-80. PMID: 23873481. 53. Ye P, Yang S, Zhang W, et al. … Drug reaction with eosinophilia and systemic symptoms (DRESS). … Comparison of drug adherence rates among patients with seven different medical conditions.

469. Hepatitis-C Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_executive.pdf
     November 01, 2012 - HCV is primarily acquired by large or repeated percutaneous exposures to blood, with injection drug … Food and Drug Administration (FDA) approved the first direct acting antiviral agents, boceprevir (trade … antiviral treatments in adults with chronic HCV infection who have not received previous antiviral drug … In addition to assessing the comparative effectiveness of different drug regimens, the review evaluates … Drug Class Review on Pegylated Interferons for Chronic Hepatitis C Infection.

470. Management of Acute Diverticulitis Topic Nomination Disposition (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/acute-diverticulitis-topic-nomination.pdf
     August 13, 2018 - and non-drug (ex. … Hartmann's procedure No intervention, other drug, other non-drug, drug vs. … non-drug, combinations Outcomes Resolution of diverticulitis, recurrent diverticulitis, avoidance … prevent recurrent diverticulitis that is relevant to KQ5.18 However, the review did not cover other drug … Does the nomination represent a health care drug, intervention, device, technology, or health care

471. Coronary-Artery-Stenting Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
     February 01, 2013 - stent, and none evaluated second-generation drug-eluting stents or bioabsorbable stents. … First, the contemporary role of IVUS guidance in drug-eluting stent placement needs to be evaluated … The potential advantage of IVUS guidance in drug-eluting and bioabsorbable stent placement requires … There are only two RCTs evaluating IVUS-guided, drug-eluting stent placement, and none with second … generation drug-eluting stents.

472. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
     August 01, 2016 - Food and Drug Administration (FDA) for these conditions. … Table 2: Summary of Evidence on the Effectiveness of Pharmacologic Interventions in Treating DBDs Drug … that might include more extensive and longer term data, including other systematic reviews and FDA drug

473. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug

474. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
     December 31, 2013 - comparative effectiveness of oral diabetes agents are considered out of date due to a newly approved drug … class and new evidence on previously reviewed drug classes … Furthermore, we conducted searches of the US Food and Drug Administration (FDA), Health Canada, and … The drug classes included in this surveillance assessment are listed below. … Experts noted that additional data on new and existing drug classes is available.

475. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
     January 01, 2007 - Although most experts consider the alpha- glucosidase inhibitors to be inferior to the other drug classes … in terms of efficacy, clinicians may find it difficult to choose between the other four drug classes … A systematic review of drug-drug interactions in subjects with diabetes would help clinicians with treatment … If each individual drug was used at a lower dose in the combination, fewer adverse events were seen. … When they analyzed specific drug-drug or drug-placebo comparisons, their results were not statistically

476. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
     September 13, 2012 - primary destruction of the venous system (such as prior history of deep venous thrombosis), injecting drug … Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services. … Drug toxicity (not allergic) i. … We plan to conduct analyses by treatment or drug class where possible. … Food and Drug Administration PTFE = polytetrafluoroethylene RCT = randomized controlled trial RFA

477. Disposition of Comments for CER 166 Calcineurin Inhibitors (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
     March 15, 2016 - For the questions that considered the effectiveness of different drug level monitoring methods (KQ1 … (Table 8 on page 34 and 35) We agree that the evidence comparing different drug monitoring times … Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring. … Ther Drug Monit. 2009 Dec;31(6):743-5. 3. Parikh BA, Siedlecki AM, Scott MG. … Ther Drug Monit. 2010 Apr;32(2):228-31. Erratum in: Ther Drug Monit. 2010 Aug;32(4):528.

478. Pharmacologic Management of Acute Pain by EMS in the Prehospital Setting Protocol Amendment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
     January 28, 2019 - • KQ 3 and 4: 4 o Administration of the initial drug at a different dose than the initial … • KQ 3 and 4: o The initial analgesic regimen (i.e. repeat the same drug and dose) studied which … KQ 3 and 4: Administration of the same drug and dose as the initial analgesic, which the patient was … population (e.g. age, gender, race/ethnicity, and pain severity), interventions (e.g. intervention drug … Ketamine for prehospital use: new look at an old drug. Am J Emerg Med. 2007;25:977-80. 16. AHRQ.

479. Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
     February 07, 2018 - choose a medication based on adverse event profiles, patient preferences, dosing schedules, costs, and drug … be used to treat depression, these classes are not considered first-line due to safety concerns and drug … Regimens should be adjusted for metabolic changes and potential drug interactions. … Drug manufacturers will have the opportunity to submit supplementary evidence and data through the Effective … based on the pharmacologic class named as the intervention and comparator, not on the individual drug

480. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
     July 18, 2011 - Food and Drug Administration. … Food and Drug Administration Web site to identify additional regulatory data. … The quality of drug studies published in symposium proceedings. Ann Int Med 1996;124:185-9. … Food and Drug Administration states higher doses and intravenous administration of haloperidol appear … (magnesium adj (sulfat$ or sulphat$)).tw. 86. drug therapy, combination/ 87. drug combinations/ 88